Carbone DP - Search Results

1

Decreased antigen presentation by dendritic cells in patients with breast cancer.

Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP. Gabrilovich DI, et al. Among authors: carbone dp. Clin Cancer Res. 1997 Mar;3(3):483-90. Clin Cancer Res. 1997. PMID: 9815709

2

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.

Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP. Winter SF, et al. Among authors: carbone dp. Cancer Res. 1992 Aug 1;52(15):4168-74. Cancer Res. 1992. PMID: 1322237

3

Mutant oncopeptide immunization induces CTL specifically lysing tumor cells endogenously expressing the corresponding intact mutant p53.

Ciernik IF, Berzofsky J, Carbone DP. Ciernik IF, et al. Among authors: carbone dp. Hybridoma. 1995 Apr;14(2):139-42. doi: 10.1089/hyb.1995.14.139. Hybridoma. 1995. PMID: 7590770

4

A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells.

Yanuck M, Carbone DP, Pendleton CD, Tsukui T, Winter SF, Minna JD, Berzofsky JA. Yanuck M, et al. Among authors: carbone dp. Cancer Res. 1993 Jul 15;53(14):3257-61. Cancer Res. 1993. PMID: 7686815

5

Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA A*0201 peptide consensus motif.

Wiedenfeld EA, Fernandez-Viña M, Berzofsky JA, Carbone DP. Wiedenfeld EA, et al. Among authors: carbone dp. Cancer Res. 1994 Mar 1;54(5):1175-7. Cancer Res. 1994. PMID: 8118802

6

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer.

Chen HL, Gabrilovich D, Tampé R, Girgis KR, Nadaf S, Carbone DP. Chen HL, et al. Among authors: carbone dp. Nat Genet. 1996 Jun;13(2):210-3. doi: 10.1038/ng0696-210. Nat Genet. 1996. PMID: 8640228

7

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.

Gabrilovich DI, Ciernik IF, Carbone DP. Gabrilovich DI, et al. Among authors: carbone dp. Cell Immunol. 1996 May 25;170(1):101-10. doi: 10.1006/cimm.1996.0139. Cell Immunol. 1996. PMID: 8665590

8

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP. Gabrilovich DI, et al. Among authors: carbone dp. Cell Immunol. 1996 May 25;170(1):111-9. doi: 10.1006/cimm.1996.0140. Cell Immunol. 1996. PMID: 8665591

9

Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.

Lee CT, Wu S, Gabrilovich D, Chen H, Nadaf-Rahrov S, Ciernik IF, Carbone DP. Lee CT, et al. Among authors: carbone dp. Cancer Res. 1996 Jul 1;56(13):3038-41. Cancer Res. 1996. PMID: 8674059

10

Puncture-mediated gene transfer to the skin.

Ciernik IF, Krayenbühl BH, Carbone DP. Ciernik IF, et al. Among authors: carbone dp. Hum Gene Ther. 1996 May 20;7(8):893-9. doi: 10.1089/hum.1996.7.8-893. Hum Gene Ther. 1996. PMID: 8727503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters